CA2323501A1 - Compose apparente a pap-1 - Google Patents

Compose apparente a pap-1 Download PDF

Info

Publication number
CA2323501A1
CA2323501A1 CA002323501A CA2323501A CA2323501A1 CA 2323501 A1 CA2323501 A1 CA 2323501A1 CA 002323501 A CA002323501 A CA 002323501A CA 2323501 A CA2323501 A CA 2323501A CA 2323501 A1 CA2323501 A1 CA 2323501A1
Authority
CA
Canada
Prior art keywords
polypeptide
seq
polynucleotide
identity
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002323501A
Other languages
English (en)
Inventor
Claudine Elvire Marie Bruck
Jean-Pol Cassart
Thierry Coche
Carlota Vinals Y De Bassols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2323501A1 publication Critical patent/CA2323501A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des polypeptides et des polynucléotides CASB47 et des procédés de production desdits polypeptides CASB47 par des techniques de recombinaison. Elle porte aussi sur des procédés d'utilisation des polypeptides et des polypeptides CASB47 dans les diagnostics, et sur des vaccins pour le traitement prophylactique et thérapeutique de cancers, notamment des cancers des ovaires, du poumon, du cerveau et du colon, de maladies auto-immunes et d'états associés.
CA002323501A 1998-03-20 1999-03-17 Compose apparente a pap-1 Abandoned CA2323501A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9806164.1A GB9806164D0 (en) 1998-03-20 1998-03-20 Novel compounds
GB9806164.1 1998-03-20
PCT/EP1999/001892 WO1999049030A1 (fr) 1998-03-20 1999-03-17 Compose apparente a pap-1

Publications (1)

Publication Number Publication Date
CA2323501A1 true CA2323501A1 (fr) 1999-09-30

Family

ID=10829070

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002323501A Abandoned CA2323501A1 (fr) 1998-03-20 1999-03-17 Compose apparente a pap-1

Country Status (6)

Country Link
EP (1) EP1062331A1 (fr)
JP (1) JP2002507417A (fr)
AU (1) AU3519199A (fr)
CA (1) CA2323501A1 (fr)
GB (1) GB9806164D0 (fr)
WO (1) WO1999049030A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1165778B1 (fr) 1999-03-11 2006-10-18 GlaxoSmithKline Biologicals S.A. Utilisations de casb618 polynucleotides et polypeptides
AU1392801A (en) * 1999-11-10 2001-06-06 Smithkline Beecham Biologicals (Sa) Casb7434, an antigen over-expressed in colon cancer

Also Published As

Publication number Publication date
EP1062331A1 (fr) 2000-12-27
JP2002507417A (ja) 2002-03-12
GB9806164D0 (en) 1998-05-20
WO1999049030A1 (fr) 1999-09-30
AU3519199A (en) 1999-10-18

Similar Documents

Publication Publication Date Title
AU766789B2 (en) Novel uses
EP1650221B1 (fr) Nouveaux composés
US7470782B2 (en) CASB618 polynucleotides and polypeptides and their use
US6635255B1 (en) CASB414:antigen overexpressed in several tumors
WO1999049055A1 (fr) Polypeptide casb12 humain, une seringue protease
WO2000058460A2 (fr) Nouveaux composes
CA2323501A1 (fr) Compose apparente a pap-1
CA2358899A1 (fr) Polypeptide
CA2358697A1 (fr) Nouveaux composes
ZA200107445B (en) CASB618 polynucleotides and polypeptides and their use.

Legal Events

Date Code Title Description
FZDE Dead